【Report】Participated in the 3rd Annual Meeting of the Japanese Society of Preemptive Clinical Medicin

THE 3RD ANNUAL CONFERENCE OF THE JAPANESE SOCIETY OF PREEMPTIVE CLINICAL MEDICINE “JSPCM KOBE 2019” WAS HELD IN KOBE, HYOGO, JAPAN ON NOVEMBER 16-17, 2019.

The Japanese Society of Preemptive Clinical Medicine was established in April 2018, and many of our members serve on the board of directors, so many doctors were present on this day.

This year we also participated in poster presentations, and many people were able to see the results of our daily research.
As case reports, Dr. Yuichi Kawai (Director, Kawai Internal Medicine Clinic ) presented a case of irritable bowel syndrome, Dr. Masahiko Shirotani (Director, Luke’s Ashiya Clinic ) presented a case of atopic dermatitis, and the Symbiosis Institute presented a comparison of transplanted diabetic monotypic mice and Japan’s only [ In addition, the Symbiosis Institute exhibited the “Ultra Fine Bubble Water Mechanism” used for the purification of bacterial solution, for which a patent has been applied for.

Dr. Masahiko Shirotani (Director, Luke’s Ashiya Clinic ) gave a lecture from our study group, and Dr. Zen Tanaka (Director, Tanaka Clinic ), Representative Director, and Dr. Noriaki Man (Director, Yorozu Clinic ), Director, served as chairpersons. Regular members Dr. Yuichi Kawai (Director, Kawai Internal Medicine Clinic ) and Dr. Katsuhiko Fukuda (Vice Director, Fukuda Internal Medicine Clinic ) also participated.

We were able to catch a glimpse of the steady activities that are creating a paradigm shift in the field of medicine. Next year’s event will be held in Tokyo from October 31 (Sat.) to November 1 (Sun.).